期刊文献+

应用血栓弹力图评价氯吡格雷血药浓度与凝血功能的相关性 被引量:1

Evaluation of the Correlation of Plasma Concentrations of Clopidogrel with Coagulation Function by Thrombelastography
下载PDF
导出
摘要 目的:考察氯吡格雷血药浓度与凝血功能的相关性。方法:选择我院2014年6月-2015年6月经皮冠状动脉介入治疗术后的急性冠状动脉综合征患者126例,术前服用维持剂量(硫酸氢氯吡格雷75 mg+阿司匹林100 mg),qd,连续服用5 d;术前1 d顿服负荷剂量(硫酸氢氯吡格雷300 mg+阿司匹林100 mg);术后继续服用维持剂量。于术后服用维持剂量的第2日,采用液相色谱-串联质谱法测定患者体内氯吡格雷的血药浓度,采用血栓弹力图仪测定患者血凝块形成时间[第一块纤维蛋白凝块形成的时间(R)+血凝块强度达到20 mm振幅的时间(K)]、纤维蛋白和血凝块加固速度(以Angle表示)及纤维蛋白凝块最终强度(MA),采用Pearson检验进行相关性分析。结果:患者体内氯吡格雷的平均血药浓度为(82.3±20.1)ng/L,(R+K)为(7.8±2.4)min,Angle为(64.1±8.7)°,MA为(60.7±7.2)mm;氯吡格雷血药浓度与(R+K)呈正相关(r=0.671,P<0.01),与Angle呈负相关(r=-0.556,P<0.01),与MA不相关(r=-0.073,P>0.05)。结论:随着氯吡格雷血药浓度的升高,(R+K)延长,而纤维蛋白和血凝块加固速度降低。 OBJECTIVE:To investigate the correlation of plasma concentrations of clopidogrel with coagulation function.METHODS:126 acute coronary syndrome(ACS) patients underwent PCI were selected from our hospital during Jun. 2014-Jun.2015. They were given maintenance dose(clopidogrel hydrogen sulfate 75 mg+aspirin 100 mg)before operation,qd,for consecutive 5 d;given loading dose(clopidogrel hydrogen sulfate 300 mg+aspirin 100 mg)at a draught one day before operation;given maintenance dose again after operation. On the second day of giving maintenance dose after operation,plasma concentration of clopidogrel was determined by LC-MS/MS;thrombelastography(TEG)was used to determine blood clot formation time [the formation time of first piece fibrae sanguis(R)+the time of blood clot strength reaching 20 mm(K)],fibrae sanguis and blood clot consolidation time(expressed by Angle) and fibrae sanguis and blood clot final strength(MA). Pearson test was adopted for relationship analysis. RESULTS:Average plasma concentration of clopidogrel was(82.3±20.1)ng/L,(R+K)was(7.8±2.4)min,Angle was(64.1±8.7)° and MA was(60.7±7.2)mm. Plasma concentration of clopidogrel was positively correlated with(R+K)(r=0.671,P〈0.01)and negatively correlated with Angle(r=-0.556,P〈0.01). There was no correlation between plasma concentration of clopidogrel and MA(r=-0.073,P〉0.05). CONCLUSIONS:As plasma concentration of clopidogrel increased,blood clot formation time prolonged while fibrae sanguis and blood clot consolidation speed decreased.
出处 《中国药房》 CAS 北大核心 2016年第14期1911-1914,共4页 China Pharmacy
基金 南京药学会-常州四药医院药学科研基金项目(No.2014YX002)
关键词 血栓弹力图 氯吡格雷 液相色谱-串联质谱法 血药浓度 相关性 Thrombelastography Clopidogrel LC-MS/MS Plasma concentration Correlation
  • 相关文献

参考文献19

  • 1Wiviott SD,Steg PG.Clinical evidence for oral antiplatelet therapy in acute coronary syndromes[J].Lancet,2015,386(9 990):292.
  • 2Vadász D,Sztriha LK,Sas K,et al.Aspirin and clopidogrel resistance:possible mechanisms and clinical relevance.Part II:potential causes and laboratory tests[J].Ideggyogy Sz,2013,66(1/2):15.
  • 3Liang Y,Hirsh J,Weitz JI,et al.Active metabolite concentration of clopidogrel in patients taking different doses of aspirin:results of the interaction trial[J].J Thromb Haemost,2015,13(3):347.
  • 4Kara?niewicz-?ada M,Danielak D,Burchardt P,et al.Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases[J].Clin Pharmacokinet,2014,53(2):155.
  • 5Silvestro L,Gheorghe MC,Tarcomnicu I,et al.Development and validation of an HPLC-MS/MS method to determine clopidogrel in human plasma.Use of incurred samples to test back-conversion[J].J Chromatogr B Analyt Technol Biomed Life Sci,2010,878(30):3 134.
  • 6Zou JJ,Ding L,Tan J,et al.CYP2C19 681G>A polymorphism and pharmacokinetics of clopidogrel in healthy Chinese volunteers[J].Pharmazie,2012,67(9):792.
  • 7樊宏伟,邹建军,林松,胡云芳,肖大伟.LC-MS/MS法同时测定人血浆中氯吡格雷及其羧酸代谢物的浓度[J].中国新药与临床杂志,2008,27(11):811-815. 被引量:22
  • 8Hobson AR,Qureshi Z,Banks P,et al.Effects of clopidogrel on"aspirin specific"pathways of platelet inhibition[J].Platelets,2009,20(6):386.
  • 9国家药典委员会.中华人民共和国药典:四部[S].2015年版.北京:中国医药科技出版社,2015:59.
  • 10Fox KA,Mehta SR,Peters R,et al.Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome:the clopidogrel in unstable angina to prevent recurrent ischemic events(CURE)trial[J].Circulation,2004,110(10):1 202.

二级参考文献37

  • 1罗心平,施海明,倪唤春,朱军,王彩萍,李剑,范维琥.负荷剂量的氯吡格雷在38例急性心肌梗死直接支架术中的应用[J].中国新药与临床杂志,2004,23(10):667-670. 被引量:8
  • 2叶颖.他汀类药物和氯吡格雷的相互作用[J].中国药房,2007,18(14):1113-1114. 被引量:7
  • 3CAVUSOGLU E, CHENG J, BHATT R, et al. Clopidogrel in the management of ischemic heart disease[J]. Heart Dis, 2003, 5 (2) : 144-152.
  • 4FURMAN MI, KRUEGER LA, LINDEN MD, et al. GPⅡb-Ⅲa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention[J]. J Thromb Haemost, 2005, 3(2): 312-320.
  • 5SINGH SS, SHARMA K, BAROT D, et al. Estimation of carboxylic acid metabolite of clopidogrel in Wistar rat plasma by HPLC and its application to a pharmacokinetic study [J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2005, 821 (2): 173-180.
  • 6LAINESSE A, OZALP Y, WONG H, et al. Bioequivalence study of clopidogrel bisulfate film-coated tablets [J]. Arzneimittelforschung, 2004, 54(9A): 600-604.
  • 7ROBINSON A, HILLIS J, NEAL C, et al. The validation of a bioanalytical method for the determination of clopidogrel in human plasma [J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2007, 848 (2): 344-354.
  • 8SINGH SS, SHARMA K, BAROT D, et al. Estimation of carboxylic acid metabolite of clopidogrel in Wistar rat plasma by HPLC and its application to a pharmacokinetic study [J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2005, 821 (2) : 173-180.
  • 9KSYCINSKA H, RUDZLI P, BUKOWSKA-KILISZEK M. Determination of clopidogrel metabolite (SR26334)in human plasma by LC-MS[J]. J Pharm Biomed Anal, 2006, 41 (2): 533-539.
  • 10Simon T, Verstuyfl C,Mary-Krause M,et al. Genetic Determinants of Response to Clopidogrel and Cardiovascular Events[J]. N Engl J Meal,2009,360(4):363-75.

共引文献47

同被引文献19

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部